Douglas JT - Search Results

1

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.

Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. Kim M, et al. Among authors: douglas jt. Eur J Cancer. 2002 Sep;38(14):1917-26. doi: 10.1016/s0959-8049(02)00131-4. Eur J Cancer. 2002. PMID: 12204675

2

Targeted adenoviral vectors.

Barnett BG, Crews CJ, Douglas JT. Barnett BG, et al. Among authors: douglas jt. Biochim Biophys Acta. 2002 May 3;1575(1-3):1-14. doi: 10.1016/s0167-4781(02)00249-x. Biochim Biophys Acta. 2002. PMID: 12020813 Review.

3

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells.

Barnett BG, Tillman BW, Curiel DT, Douglas JT. Barnett BG, et al. Among authors: douglas jt. Mol Ther. 2002 Sep;6(3):377-85. doi: 10.1006/mthe.2002.0670. Mol Ther. 2002. PMID: 12231174 Free article.

4

Adenovirus-mediated gene delivery to dendritic cells.

Timares L, Douglas JT, Tillman BW, Krasnykh V, Curiel DT. Timares L, et al. Among authors: douglas jt. Methods Mol Biol. 2004;246:139-54. doi: 10.1385/1-59259-650-9:139. Methods Mol Biol. 2004. PMID: 14970589

5

Targeted adenoviral vectors for cancer gene therapy (Review).

Douglas J, Curiel D. Douglas J, et al. Int J Oncol. 1997 Aug;11(2):341-8. doi: 10.3892/ijo.11.2.341. Int J Oncol. 1997. PMID: 21528220

6

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Krasnykh VN, et al. Among authors: douglas jt. J Virol. 1996 Oct;70(10):6839-46. doi: 10.1128/JVI.70.10.6839-6846.1996. J Virol. 1996. PMID: 8794325 Free PMC article.

7

Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.

Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP, Baird A, Campain JA, Curiel DT. Goldman CK, et al. Among authors: douglas jt. Cancer Res. 1997 Apr 15;57(8):1447-51. Cancer Res. 1997. PMID: 9108444

8

Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.

Douglas JT, Curiel DT. Douglas JT, et al. Neuromuscul Disord. 1997 Jul;7(5):284-98. doi: 10.1016/s0960-8966(97)00053-9. Neuromuscul Disord. 1997. PMID: 9267842 Review.

9

Targeted gene delivery by tropism-modified adenoviral vectors.

Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Douglas JT, et al. Nat Biotechnol. 1996 Nov;14(11):1574-8. doi: 10.1038/nbt1196-1574. Nat Biotechnol. 1996. PMID: 9634824

10

Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.

Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT. Miller CR, et al. Among authors: douglas jt. Cancer Res. 1998 Dec 15;58(24):5738-48. Cancer Res. 1998. PMID: 9865732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters